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1188Objective: A key challenge to applying cell transplantation to treat severely damaged myocardium is in deliv-
ering large numbers of cells with minimum cell loss. We developed a new implantation method using skeletal
myoblast (SMB) sheets, wrapped with an omentum flap as a blood supply to deliver huge numbers of SMBs to
the damaged heart. We examined whether this method could be used to deliver a large amount of cells to dete-
riorated porcine myocardium.
Methods:Cell sheets were obtained by culturingmini-pig autologous SMB cells on temperature-responsive cul-
ture dishes. Myocardial infarction was induced by placing an ameroid constrictor around the left anterior de-
scending artery. The mini-pigs were divided into 4 treatment groups (n ¼ 6 in each): cell sheets with
omentum, cell sheets only, omentum only, and sham operation. Each animal implant consisted of 30 cell sheets
(1.53 107 cells per sheet). Six 5-layer constructs were each placed on a different area, immediately adjacent to
but not overlapping one another, to cover the infarct and border regions.
Results: The new regenerative cell delivery system using SMB sheets covered and wrapped with omentum re-
sulted in (1) a significantly reduced infarct size causing, at least in part, a thin scar with thick well-vascularized
cardiac tissue; (2) increased angiogenesis, as determined by a significantly higher vascular density; and (3) im-
proved cardiac function, as determined by echocardiography, compared with the conventional method (SMB
sheet implantation).
Conclusions: This cell delivery system shows potential for repairing the severely failed heart. (J Thorac
Cardiovasc Surg 2011;142:1188-96)Heart failure is a frequent and life-threatening disorder, de-
spite recent medical and surgical advances. Myocardial re-
generative therapy is gaining interest as a means for
improving left ventricular (LV) function in patients with
end-stage heart disease.1-3 However, a recent clinical trial
of cell transplantation by needle injection reported
slightly disappointing results.2-4 The main drawbacks of
cell transplantation by needle injection appear to be poor
retention and survival of the injected cells, local
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The Journal of Thoracic and Cardiovascular Surneedle itself, and the potential for lethal arrhythmias. We
have been investigating cell-sheet techniques for delivering
cells to severely damaged myocardium more efficiently,
without damaging the myocardium, and, consequently,
more effectively. This technique provides better improve-
ment of cardiac function than obtained with the needle
cell-injection method.5-7
The greatest advantage of the cell-sheet technique is that
the sheet consists only of cells, which produce an extracel-
lular matrix without requiring an artificial scaffold. The cell
sheet has a high ability to integrate with native tissues,
because the adhesion molecules on its surface are pre-
served.5-7 The layered grafts must be carefully prepared to
avoid tearing, but they themselves are strong, flexible, and
easy to work with.
It has been suggested that an increased number of im-
planted skeletal myoblast (SMB) sheets is related to better
results, such as improved cardiac function and angiogene-
sis, less fibrosis, and less hypertrophy, with the amounts
of secreted cytokines dependent on the number of cell
sheets used.7 However, cell sheets with more than 5 layers
show areas with disorganized vasculature, presumably
because of insufficient supplies of blood, oxygen, and
nutritients.7,8 Thus, in applying cell transplantation to the
severely damaged myocardium, a key challenge is in
improving the blood perfusion of the implanted cells sogery c November 2011
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FIGURE 1. Study protocol for the assessment of cardiac function and his-
tologic analysis.
Abbreviations and Acronyms
LAD ¼ left anterior descending coronary
artery
LV ¼ left ventricular
LVEDV ¼ left ventricular end-diastolic volume
LVEF ¼ left ventricular ejection fraction
LVESV ¼ left ventricular end-systolic volume
MI ¼ myocardial infarction
O group ¼ omentum only
RT-
PCR
¼ real-time polymerase chain reaction
S group ¼ cell sheets only
SMB ¼ skeletal myoblast
SO
group
¼ cell sheets wrapped with omentum
STAT3 ¼ signal transducer and activator of
transcription 3
VEGF ¼ vascular endothelial growth factor
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Sthat large numbers of regenerative cells can be delivered
with minimal cell loss.
The omentum is reported to potentially provide revascu-
larization for the ischemic myocardium,9 release a number
of angiogenic cytokines,10,11 supply stem cells, and
attenuate inflammation.12 The omentum was once com-
monly used in surgical revascularization to treat ischemic
heart disease; however, omentopexy alone is not very effec-
tive for supporting the angiogenesis needed in the infarcted
area for rapid recovery.9 On the basis of those findings, we
speculated combining SMB sheets with omentummight en-
hance survival of the implanted cells by improving angio-
genesis. Thus, as a novel method for implanting large
amounts of cells, we developed a cell-delivery system using
SMB sheets wrapped and covered with omentum flap as an
external source for blood flow. We hypothesized that this
method could replace the myocardial infarction (MI) scar
with cell-sheet–based cardiac tissue in the pig heart.MATERIALS AND METHODS
All studies were performed with the approval of the institutional ethics
committee of Osaka University. Humane animal care was used in compli-
ance with the ‘‘Principles of Laboratory Animal Care’’ formulated by the
National Society for Medical Research and the ‘‘Guide for the Care and
Use of Laboratory Animals’’ prepared by the Institute of Animal Resources
and published by the National Institutes of Health (Publication No 85-23,
revised 1996). The authors had full access to the data and take full respon-
sibility for its integrity. All the authors have read and agreed to the manu-
script as written. All procedures and evaluations, including the assessment
of cardiac parameters, were carried out in a blinded manner.
Animal Models and Study Protocol (Figure 1)
Thirty-seven female mini-pigs (8-10 months old; Japan Farm Co Ltd,
Kagoshima, Japan) weighing 20 to 25 kg were used in these experiments.The Journal of Thoracic and CarThe mini-pigs were anesthetized with an intravenous administration of ket-
amine (6 mg/kg) and sodium pentobarbital (10 mg/kg) for endotracheal in-
tubation and then maintained with inhaled sevoflurane (15%-2%). The
pericardial spacewas exposed by left thoracotomy through the fourth inter-
costal space. The distal portion of the left anterior descending coronary ar-
tery (LAD) was directly ligated as ischemic preconditioning to reduce the
occurrence of lethal ventricular arrhythmia, followed by placement of an
ameroid constrictor around the LAD just distal to the left circumflex coro-
nary artery branching.5,13 The muscle and skin were closed in layers, and
the mini-pigs were then taken off the anesthetics. Eleven (30%) of the
study animals died in the early postoperative period. This technique pro-
duced an ischemic cardiomyopathy model that reflected clinical relevance
and can be used for appropriate preclinical studies with minimal procedure-
related mortality.
Computer-generated random allocation generated 4 randomized study
groups 1 week after MI. Autologous cells were isolated and grown in cul-
ture for 3 weeks to prepare samples for implantation. Four weeks after MI
induction, the mini-pigs were again placed under general anesthesia for
echocardiography followed by either cell-sheet implantation or a sham op-
eration. Two mini-pigs whose LV ejection fractions (LVEFs) were above
40% before treatment, as measured by transthoracic echocardiography us-
ing the Simpson method, were excluded from the study. At 4 and 8 weeks
after either cell-sheet implantation or sham operation, the mini-pigs again
underwent general anesthesia for echocardiographic examination. The
mini-pigs were humanely killed after the 8-week echocardiography mea-
surements for histologic and biochemical analyses of the heart tissue.
Preparation and Grafting of SMB Cell Sheets
Autologous skeletal muscle weighing approximately 10 to 15 g was re-
moved from the quadriceps femoris muscle, and purified autologous SMB
cells were cultured for 3 weeks to prepare them for implantation, as de-
scribed previsously.5 Autologous SMBs are precursor cells of adult myofib-
ers and feature several advantages, including autologous origin, high invitro
scalability, lack of tumorigenicity (owing to their myogenic lineage restric-
tion), and strong resistance to hypoxia after ischemia. The cells were incu-
bated in 60-mm temperature-responsive culture dishes (UpCell; Cellseed,
Tokyo, Japan) at 37C for 24 hours (1.5 3 107 cells per dish). The dishes
were then transferred to another incubator, set at 20C, for 1 hour to release
the cultured cells as intact cell sheets. Under this protocol, the SMBs spon-
taneously detached from the plate as a free-floating monolayer cell sheet.
Grafting the SMB Cell Sheet Wrapped With
Omentum
The mini-pigs with MI were divided into 4 treatment groups (n ¼ 6 in
each): cell sheets wrapped with omentum (SO group), cell sheets only
(S group), omentum only (O group), and sham operation (sham group).
Each animal in the SO and S groups received approximately 30 cell sheets
(1.5 3 107 cells per sheet) with the total cell number being 4.5 3 108.diovascular Surgery c Volume 142, Number 5 1189
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were placed on the epicardium of the ischemic area (LAD region) and
stitched in place around the edge. In the SO group, a small upper midline
laparotomy and median sternotomy were performed to move omentum
from the peritoneal space into the mediastinal space, preserving the arch
structure of the left gastroepiploic artery. We created a hole in the dia-
phragm and passed the omentum flap through the hole into the pericardial
cavity. Five-layer cell sheets of SMBs were wrapped with omentum and
then covered with the harvested omental flap, because a maximum of 5
cell-sheet layers can be implanted in one place.7,8 Six 5-layer constructs
were each placed on a different area to cover the infarct and border regions.
The operations were performed with the animals under general anesthesia.
Histologic and Immunohistochemical Analyses
Eight weeks after the treatment, the hearts were dissected and embedded
in optimum cutting temperature compound, snap-frozen in liquid nitrogen,
and cut into 5-mm thick sections. The paraffin-embedded sections were
fixed in 4% paraformaldehyde and stained with hematoxylin–eosin
(Figure 2) or Masson trichrome (Figure 3). The percentage of infarct
area was quantified as the positively stained LV area/total LV area. The
stained and total LVareas were obtained by tracing using Image J software
at the mid-LV level, where the base of the papillary muscles is clearly
depicted.
So that vascular density could be evaluated in the border area, the cry-
osectioned samples were immunolabeled with anti–von Willebrand fac-
tor antibody (1:250 dilution; Dako, Glostrup, Denmark) (Figure 4).
The number of positively stained capillary vessels that were 5 to 10
mm in diameter in the peri-infarct border-zone myocardium in 16 indi-
vidual randomly selected fields per heart was counted under high-
power magnification (3200). The numbers from the 16 fields wereFIGURE 2. Macroscopic (340) views of the heart in the 4 groups (hematoxyli
omentum; S group, SMB sheets only; O group, omentum only; sham group, sh
1190 The Journal of Thoracic and Cardiovascular Suraveraged to determine the vascular density (per square millimeter).
The stained slides were viewed on a BioZero laser scanning microscope
(Keyence, Osaka, Japan).
The following antibodies were used to identify SMBs: the primary an-
tibodies were anti-smooth muscle actin, anti-vimentin, anti-desmin, and
anti-skeletal myosin (fast) (all from Dako); the secondary antibodies
were goat anti-mouse and anti-rabbit immunoglobulin G (Invitrogen,
Leek, The Netherlands).
Analysis of mRNA Expression
Total RNAwas extracted from cardiacmuscle tissue, reverse transcribed
into cDNA using TaqMan reverse transcription reagents (Applied Biosys-
tems, Stockholm, Sweden), and real-time polymerase chain reaction
(RT-PCR) was performed with an ABI PRISM 7700 machine (Applied
Biosystems).14 For each gene, RNA samples were prepared and assayed
in triplicate. RT-PCRwas used to determine the expressions of vascular en-
dothelial growth factor (VEGF) and signal transducer and activator of tran-
scription 3 (STAT3) in our in vivo experiments. The average copy number
of gene transcripts for each sample was normalized to that for glyceralde-
hyde-3-phosphate dehydrogenase.
Echocardiography: Measurements of Global LV
Function
Global cardiac function was assessed using commercially available
echocardiographic equipment with a 4.0-MHz transducer (Aplio; Toshiba,
Otawara, Japan) before and 4 and 8 weeks after cell-sheet implantation. Echo-
cardiographic measurements included LV end-diastolic and end-systolic vol-
umes (LVEDV and LVESV, respectively) and LVEF. LVEF was calculated
as follows: LVEF ð%Þ ¼ 1003 ðLVEDVLVESVÞ=ðLVEDVÞ.n–eosin staining). SO group, skeletal myoblast (SMB) sheets wrapped with
am operation.
gery c November 2011
FIGURE 3. Macroscopic (340) views of the heart in the 4 groups (Masson trichrome staining). Infarct area: The SO group showed a significant
improvement in the infarct area of the whole heart. Abbreviations as in Figure 2. *P<.05.
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SPSS software (version 11.0, SPSS, Inc, Chicago, Ill) was used for sta-
tistical analyses. Continuous values are expressed as the mean  standard
deviation. The significance of differences was determined using a 2-tailed
multiple t test with Bonferroni correction following analysis of variance for
individual differences.FIGURE 4. Microscopic (3200) views of sections of the peri-infarct border-z
the 4 groups (bar ¼ 20 mm). Vascular density: The SO group showed a signifi
factor antibody. Abbreviations as Figure 2. N>4 in each group. *P<.05.
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Modulation of Myocardial Structure
Myocardial structural components, including fibrosis and
vascularity, were assessed by hematoxylin–eosin staining,
Masson trichrome staining, and immunohistochemistryone region stained with the von Willebrand factor antibody (factor VIII) in
cant improvement in vascular density, as assessed by anti–von Willebrand
diovascular Surgery c Volume 142, Number 5 1191
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FIGURE 5. A, Microscopic (3200) views of the infarct region in the SO group (alpha smooth muscle actin staining). B, Microscopic (3200) views of the
infarct region in the SO group (vimentin staining). C, Microscopic (3200) views of the infarct region in the SO group (fast type myosin heavy chain stain-
ing). D and E, Microscopic (3200) views of the heart (desmin staining). SO group, SMB sheets wrapped with omentum.
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cavity of the LV was enlarged in the O and sham groups,
whereas the global myocardial structure was well main-
tained in the SO and S groups, as assessed by hematoxy-
lin–eosin staining (Figure 2). Collagen was densely
accumulated in the infarct area and globally distributed in
the remote area after the sham operation, whereas less col-
lagen had accumulated in both the infarct and remote areas
in the other 3 groups compared with the sham group, as as-
sessed byMasson trichrome staining. The size of the infarct
area, quantitatively assessed by computer-based planimetry1192 The Journal of Thoracic and Cardiovascular Surof Masson trichrome–stained hearts, was significantly
smaller in the SO group than in the other 3 groups
(Figure 3). The vascular density, assessed by immunohisto-
chemistry for anti–von Willebrand factor, was significantly
greater in the SO group than in the other 3 groups (Figure 4).
Many alpha-smooth muscle actin- and vimentin-positive
cells were present in the implanted sheets in the SO group;
these cells were negative for fast-type myosin heavy chain
and desmin (Figure 5, A–D). However, a few desmin-
positive cells were also detected at the implanted site
(Figure 5, E). These results suggested that most of thegery c November 2011
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whereas a few expressed the phenotype of SMBs. Al-
though these cells might have played an important role
in the myocardial regeneration after SMB sheet implanta-
tion, their origin and characteristics have not been fully
evaluated. Further study will be needed to elucidate the
function of these cells and clarify the mechanisms of myo-
cardial regeneration.
mRNA Expressions After Cell-Sheet Implantation
The expression of a variety of molecules that are intra-
myocardially expressed and potentially related to reverse
LV remodeling was assessed by RT-PCR. Among them,
the relative expression levels of VEGF and STAT3 mRNA
were highest in the SO group, suggesting that the combina-
tion of SMB sheets and omentum accelerated the secretion
of angiogenesis-related cytokines (ie, VEGF and STAT3)
from the SMB sheets in vivo (Figure 6).
Cardiac Functional Recovery
Serial changes in the global systolic and diastolic LV
function after cell-sheet implantation were assessed by con-
ventional echocardiography. After the sham operation,
LVEDV and LVESV tended to increase until 8 weeks,
whereas the LVEF and anterior wall thickness did not
change. In contrast, LVEDV did not change in the SO
group, but LVESV tended to decrease in the SO and S
groups. LVEF increased significantly at 4 and 8 weeks after
treatment in the SO group compared with the baseline
value. At 4 and 8 weeks after treatment, LVESV was signif-
icantly smaller and LVEF significantly greater in the SO
group than in the S group, whereas there was no significant
difference in LVEDV between them. The anterior wallVEGF STAT3
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FIGURE 6. mRNA expressions in implanted infarcted hearts were deter-
mined by real-time PCR using porcine primers. The expressions of vascular
endothelial growth factor (VEGF) and signal transducer and activator
of transcription 3 (STAT3) mRNA were significantly increased in the
SO group compared with the other groups. Abbreviations as in Figure 2.
N>4 in each group. *P<.05.
The Journal of Thoracic and Carthickness increased significantly at 8 weeks after treatment
in the SO group compared with its baseline value; this
change was significantly larger than that in the sham group
(Figure 7).
DISCUSSION
The major findings of this study were that a new regener-
ative cell delivery system using SMB sheets covered and
wrapped with omentum resulted in the following benefits
compared with the conventional method (ie, SMB sheet im-
plantation): (1) a reduced infarct area that led, at least in
part, to a thin scar with thick well-vascularized cardiac tis-
sue; (2) angiogenesis induction; and (3) improved cardiac
function. Our data suggest that this new cell-delivery sys-
tem acted in large part by enhancing the paracrine effect
of the SMBs.
The mechanism of the restoration of damaged myocar-
dium by SMB sheet implantation is complex, involving
many pathways.5-7 Recent reports describe the beneficial
results of SMB sheet implantation in several animal
experimental models and patients with heart failure. These
benefits were primarily attributed to the secretion of
cytokines from the implanted cell sheets (ie, a paracrine
effect). It has been suggested that regenerative therapy
for the severely damaged myocardium, in which large
numbers of cells must be delivered with minimal cell
loss, may be achieved by improving the blood perfusion
in the region of implanted cells.7,8 The general intention
is to protect the implanted cells from ischemic injury
and necrosis by inducing cardiac protective responses
(eg, angiogenesis and attenuation of inflammation). A
previous study15 reported that angiogenic factors, such as
endothelial cells and some angiogenic growth factors,
can enhance angiogenesis to improve the survival of
thick-layered cardiomyocyte sheets applied to the dam-
aged myocardium. Shimizu and associates8 reported that
transplanted 3-layered cardiomyocyte sheets could be vas-
cularized in subcutaneous tissue without necrosis, but
sheets with 4 or 5 layers had areas with disorganized vascu-
lature and primary ischemia. To overcome this limitation,
they performed repeated transplantations of triple-layer
grafts, which created a thick myocardium with a well-
organized microvascular network.8 However, technical
hurdles still need to be overcome before a similar method
can be clinically applied in humans.
In the present study, we demonstrated that the implanta-
tion of SMB sheets in combination with omentum was su-
perior to conventional SMB-sheet implantation. The use
of an omentum flap to provide revascularization within
the ischemic myocardium was previously performed in pa-
tients with ischemic heart disease.9 Although omentopexy
alone was not effective for eliciting a rapid recovery, recent
basic research studies have suggested a mechanism by
which omentum tissue induces angiogenesis.10,11diovascular Surgery c Volume 142, Number 5 1193
FIGURE 7. Echocardiographic analysis. The SO group showed less ventricular remodeling and greater degrees of improved anterior wall thickness and
cardiac function than did the S group.Pink line, SO group; red line, S group; blue line,Ogroup; green line, sham group; LVEDV, left ventricular end-diastolic
volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; other abbreviations as in Figure 2. N ¼ 6 in each group.
*P<.05.
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surgeons to stimulate revascularization. Omentum also
has the potential to supply fat-derived stem cells9 and vari-
ous cytokines10,11 and to attenuate inflammation.12 The ad-
ipocytes in omentum release a number of angiogenic
growth factors, such as VEGF, suggesting that omentum
flap can act as a physiologic exogenous source of multiple
angiogenic factors that act synergistically to promote arte-
riogenesis.16 Our results support the idea that the interposed
omentum enhances the cardiac protection provided by the
superimposed SMB sheets, such as by inducing angiogene-
sis, increasing the blood flow, and prolonging cell survival
(in part by attenuating inflammation and protecting the cells
from apoptosis). Other experimental studies aimed at en-
hancing the effects of omentopexy have been reported.
Ruel and associates16 demonstrated that a gastric submuco-
sal patch has excellent angiogenic effects when used as an
endogenous source of growth factors in a swine model of
chronic myocardial ischemia. Kanamori and colleagues17
showed that omentopexy enhances the angiogenic effect
of cell therapy in a swine model of acute MI. Compared
with these studies, our new method seems safer and less
invasive because it does not require gastrectomy or bone
marrow aspiration.1194 The Journal of Thoracic and Cardiovascular SurOn the basis of our present results, we speculate that the
myocardial functional recovery obtained with the combined
method was associated with the upregulation of angiogenic
cytokines (eg, VEGF, STAT3) and with increased angiogen-
esis and blood flow. In addition, the reduced infarct area, as
determined by evaluating Masson trichrome–stained hearts,
indicates that the animal model used in the present study
may be one of hibernating myocardium rather than of
chronic infarction.13 Together with the paracrine effects
of the implanted SMB sheet, humoral substances from the
omentum might have had beneficial effects on the native
cardiomyocytes and viable surrounding muscle cells, pre-
venting global myocardial remodeling. One possible mech-
anism to explain our results is that the SMB sheet with
omentum implantation therapy induced the release of cyto-
kines and enhanced the development of the microvascula-
ture (ie, microcirculation, which is particularly vulnerable
to injury during ischemia), which on reperfusion rescued
the hibernating myocardium, thereby enhancing the recov-
ery of myocardial performance. A recent report mentioned
a possible role of stromal cell–derived factor 1 in recruiting
stem cells. Because stromal cell–derived factor 1 is secreted
in muscle tissue, and muscle satellite cells express func-
tional CXCR4 receptors, the implanted SMBs may servegery c November 2011
Shudo et al Evolving Technology/Basic Scienceto recruit stem cells to the site of damage, where they pro-
mote heart repair.6 Nevertheless, it remains to be deter-
mined what cytokines play a major role in generating
therapeutic effects among the many complex molecular
and cellular mechanisms involved.
We could find no ventricular premature beat by Holter
electrocardiographic analysis after the treatment (data not
shown). We5 previously reported that rat and porcine MI
models show less arrhythmia after being treated with
SMB-sheet implantation than with needle injection. We
speculate that the needle damages the myocardium, which
may induce arrhythmia. In contrast, the SMB sheet implan-
tation technique does not normally injure the myocardium.
Moreover, we did not observe any cases of lethal ventricular
arrhythmia in animals implanted with SMB sheets wrapped
with omentum.E
T
/B
SCONCLUSIONS
A new cell-delivery method using SMB sheets combined
with omentum allowed us to implant large numbers of
SMBs in a porcine MI model. The implanted sheets became
well-vascularized cardiac tissue, with less scarring and im-
proved cardiac function over that of the animals receiving
SMB sheets alone. This method may be applicable for re-
pairing the severely failing heart.
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I thank the authors for the courtesy of providing me with a copy
of their manuscript well in advance of the meeting. I congratulate
them as well for a very elegantly performed and executed study,
and I will confirm with the audience that the results shown here
are just a small tip of the iceberg of the complete results presented
in the manuscript. Most important, the manuscript contains a lot of
functional data that, unfortunately, owing to time constraints,
Dr Shudo was unable to present.
Having said that, I have a few questions with regard to this
study. In the manuscript, it was not quite clear to me whether the
number of cell sheets delivered were different between the omen-
tum group (O group) and the cell-sheets-only group (S group). You
mentioned that to achieve the omentumwrapping you had a limita-
tion of 5 sheets in the omentum-plus-cell group (SO group). Was
that different from the total number of cell sheets implanted in
the cell-sheets-only group (S group)?
Dr Shudo. Thank you for your useful comments, Dr Rao.
In this study we used 30 cell sheets total. On the basis of our re-
sults in the previous studies, the increase in the number of im-
planted cell sheets was related to the favorable results, such as
enhancing the paracrine effect and improving cardiac function.
However, these previous studies also suggested that more than 5
layers of SMB sheets had disorganized vasculature in the im-
planted site, maybe owing to the primary ischemia. Therefore, in
this study, at most 5 layers were attached in one place and covered
and wrapped with the omentum to support the angiogenesis.
Dr Rao. I will point to some of the LV function data that were
presented in your manuscript. You measured LV function both at 4
weeks and 8 weeks after LAD ligation. What was striking to me
was that in most models of LAD ligation there is continued dete-
rioration in LV function in the control groups. In contrast, in your
study, the 3 relative control groups had stabilization of their LVdiovascular Surgery c Volume 142, Number 5 1195
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Sfunction from 4 to 8 weeks with a continued improvement in LV
function in the omentum-plus-cell-transplant group (SO group).
Can you explain why the LV function appeared to stabilize in
your model.
Dr Shudo. In this study,MIwas induced by first ligating the dis-
tal portion of the LAD for ischemic preconditioning, followed by
placement of the ameroid constrictor around the main trunk of the
LAD, just distal to the left circumflex artery branching. It has been
reported that the ameroid ring was estimated to occlude inside
completely about 2 weeks after being placed in vivo. As you men-
tioned (and as shown in one slide), LVEF seems to be unchanged 1,
2, and 3 months after placement of the ameroid ring, whereas
LVEDVand LVESV indices significantly increased gradually after
induction of MI. Therefore, I would like to mention that LV re-
modeling was successfully obtained in this model in this study.
Dr Rao. I have 1 final question. You showed that the cell reten-
tion was approximately double that with the addition of the omen-
tum wrapping, 60% cell retention versus 30% with the cell sheet
alone. Yet for almost all of your end points there was absolutely
no benefit to cell sheet implantation alone, which is obviously in
contrast to many of the studies done previously with SMBs show-
ing a benefit in function, angiogenesis, et cetera. Can you explain
why your cell sheet transplant alone had absolutely no benefit in
this model.1196 The Journal of Thoracic and Cardiovascular SurDr Shudo. That seems to be a bit confusing. We have obtained
good results even in the cell-sheet-only group (S group), too. How-
ever, we would like to focus on the preferable results of the new
cell-implantation method.
Thank you again for your comments and good questions.
Dr Paul Kurlansky (Miami, Fla). I have no disclosures.
This was very interesting work. I have just 2 questions. First,
what exact cells or mixture of cells are you putting into the cell
sheets? Second, have you looked histologically at the hearts to
see if you actually have myocardial regeneration or if you just
have hypertrophy and preservation of the residual border zone
myocardium?
Dr Shudo. Thank you so much. Regarding the first question, al-
though this is unpublished information, we performed the experi-
mental study about SMBs mixed with adipose tissue, derived
mesenchymal stem cells. This model shows priority to the SMB
cell-sheet-only group (S group).
Regarding the analysis of border zone, our study using tissue
Doppler echocardiography and speckle tracking echocardiogra-
phy data showed that regional functional recovery was signifi-
cantly greater in the infarct border region. This result may
support the idea that cell-sheet-with-omentum therapy pre-
vented progression of MI by supporting the hibernating
myocardium.gery c November 2011
